Chambers Clinic
- Semaglutide
- Tirzepatide
- Retatrutide
- Medical Weight Loss
United States
Retatrutide is an investigational drug from Eli Lilly with no FDA approval, so no pharmacy can fill a prescription for it. The documented routes to it are clinical trials and Lilly's expanded access program, which only a treating physician can request. Clinics on this list are listed because their own websites say they offer retatrutide. Regenerated.com has not verified what any clinic supplies, and products sold as "research peptides" are not the trial medicine.
This is the national page for retatrutide on Regenerated.com, covering clinics across the United States that record the treatment. Retatrutide, known in research papers by the code LY3437943 and often called a triple agonist or "triple G" drug, is an investigational peptide that activates three hormone receptors at once: GLP-1, GIP and glucagon. In clinical trials it is given as a subcutaneous injection once a week, with the dose raised in steps to limit stomach side effects. In practice the clinicians who discuss it are obesity medicine physicians, endocrinologists, primary care doctors and the research teams running trials. Patients usually compare it with semaglutide and tirzepatide, the approved GLP-1 based medicines, and with peptide therapy, metabolic programs and bariatric surgery.
The trial program is unfinished, and the regulatory status is the most important fact on this page. Retatrutide is not FDA approved for any use. A phase 2 trial in adults with obesity, published in the New England Journal of Medicine in 2023, reported large average weight loss, and phase 3 trials in obesity, type 2 diabetes, knee osteoarthritis, sleep apnea and fatty liver disease are under way or reporting. Until regulators review that full body of data, long term safety, durability of results and the right patients remain open questions. Because it is not an approved drug, retatrutide cannot be lawfully compounded, and vials sold online as "research peptides" are unregulated products of unknown content and purity.
The candidates studied so far are adults with obesity, or with overweight plus a weight related condition such as type 2 diabetes, high blood pressure or joint pain. The documented ways to receive retatrutide today are a clinical trial, which screens each volunteer, supplies the study drug and monitors closely, or a request by a treating physician to Lilly's expanded access program. People who are pregnant or planning pregnancy, people with a history of pancreatitis, and people with a personal or family history of medullary thyroid cancer are usually excluded from trials of this drug class and told to look elsewhere. Anyone who qualifies for an approved GLP-1 medicine is generally advised to discuss that option with their own clinician first.
Supply works differently for an investigational drug. Trial sites sit in academic medical centers, hospital research programs and private research clinics in many states, and enrollment opens and closes on the sponsor's timeline. Some weight loss clinics, medical spas and peptide studios list retatrutide or mention it, and a listing on this page does not mean the clinic can lawfully prescribe it. Patients sometimes travel to reach an open trial, so check a trial's location and visit schedule before committing.
Before booking anywhere, ask who supervises your care and whether the clinic is an enrolling trial site. Ask exactly what would be administered and its source: a sponsor supplied study drug inside a registered trial, an approved medicine instead, or an unapproved product. Ask for written disclosure of risks, including nausea, vomiting, diarrhea, raised heart rate, gallbladder problems and pancreatitis. Ask what a quote itemizes, since trial participation is normally free while a clinic visit is not, and what follow up and monitoring look like.
This national list is not for sale. Organic order is never paid ranking, Featured slots are labeled and capped, and Verified means the clinic completed credential checks, not that it spent money. Regenerated.com is free for patients, and inclusion in the directory is not an endorsement. Use the state hubs below the list to see where these clinics are.
For mechanism, trial results and terms in more depth, read the retatrutide guide. Two short explainers cover how listings work: How to read a Regenerated city hub and Featured vs Verified vs organic.
Explore by state